Bilateral interstitial keratitis following COVID-19: a case report.
| Title: | Bilateral interstitial keratitis following COVID-19: a case report. |
|---|---|
| Authors: | Daher ND; Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, 840 Walnut Street, Suite 920, Philadelphia, PA, 19107, USA.; Syed ZA; Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, 840 Walnut Street, Suite 920, Philadelphia, PA, 19107, USA. zsyed@willseye.org. |
| Source: | BMC ophthalmology [BMC Ophthalmol] 2023 Oct 13; Vol. 23 (1), pp. 414. Date of Electronic Publication: 2023 Oct 13. |
| Publication Type: | Case Reports; Journal Article |
| Language: | English |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : BioMed Central, [2001- |
| MeSH Terms: | Epstein-Barr Virus Infections*/complications ; COVID-19*/complications ; Keratitis*/diagnosis ; Keratitis*/etiology; Male ; Humans ; Middle Aged ; Herpesvirus 4, Human ; SARS-CoV-2 |
| Abstract: | Background: Although the primary target of severe acute respiratory syndrome coronavirus 2 is the respiratory tract, the expression of the angiotensin-converting enzyme 2 receptor in other tissues facilitates viral entry in others parts of the body, including ocular structures. Ocular manifestations may occur before, during, or after systemic infection.; Case Presentation: We report the case of a 60-year-old male who presented with bilateral interstitial keratitis after the onset of COVID-19, with ocular symptoms starting within 7 days after systemic symptoms. Laboratory investigation did not identify any alternative etiology for his disease, although the possibility of Epstein-Barr virus or herpes simpex virus could not be definitively ruled out. The patient had already developed significant corneal scarring and visual debilitation by the time topical steroids were initiated, and his final corrected visual acuity with rigid gas permeable contact lenses was 20/50 and 20/80 in the right and left eye, respectively.; Conclusions: The involvement of ocular tissue by the virus can lead to permanent sequelae such as severe visual loss, and clinicians should be aware of and recognize ophthalmic manifestations of this disease to prompt early intervention.; (© 2023. BioMed Central Ltd., part of Springer Nature.) |
| References: | Lancet. 2020 May 23;395(10237):1610. (PMID: 32405105); Ocul Surf. 2019 Jan;17(1):40-49. (PMID: 30317007); J Fr Ophtalmol. 2019 Jun;42(6):e229-e237. (PMID: 31103357); Cornea. 1998 May;17(3):278-81. (PMID: 9603383); Cornea. 2021 Jan;40(1):123-124. (PMID: 32889957); Neurology. 2020 Sep 1;95(9):411. (PMID: 32868480); J Pathol. 2021 Jul;254(4):307-331. (PMID: 33586189); Ocul Surf. 2021 Jan;19:190-200. (PMID: 32502616); BMJ Open Ophthalmol. 2020 Sep 06;5(1):e000563. (PMID: 34192152); Ocul Surf. 2020 Oct;18(4):537-544. (PMID: 32544566); N Engl J Med. 2020 Jun 25;382(26):2574-2576. (PMID: 32302082); J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104982. (PMID: 32689586); Orbit. 2022 Jun;41(3):374-377. (PMID: 33402004); Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa249. (PMID: 32661498); Can J Ophthalmol. 2020 Aug;55(4):e125-e129. (PMID: 32284146); BMC Infect Dis. 2023 Apr 26;23(1):259. (PMID: 37101275); Acta Ophthalmol. 2020 Dec;98(8):e1056-e1057. (PMID: 32483943); Clin Exp Optom. 2020 Jul;103(4):418-424. (PMID: 32406140); Curr Opin Ophthalmol. 2020 Nov;31(6):489-494. (PMID: 33009081); J Ophthalmic Vis Res. 2021 Jan 20;16(1):103-112. (PMID: 33520133); J Fr Ophtalmol. 2022 Apr;45(4):e175-e177. (PMID: 35033376); Neurology. 2020 Aug 4;95(5):e601-e605. (PMID: 32303650); Indian J Ophthalmol. 2020 Oct;68(10):2291-2293. (PMID: 32971697); Am J Ophthalmol Case Rep. 2021 Jul 22;23:101175. (PMID: 34368498) |
| Contributed Indexing: | Keywords: COVID-19; Interstitial keratitis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| Entry Date(s): | Date Created: 20231013 Date Completed: 20231101 Latest Revision: 20231121 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC10571384 |
| DOI: | 10.1186/s12886-023-03160-4 |
| PMID: | 37833623 |
| Database: | MEDLINE |
Case Reports; Journal Article